NEVRO CORP. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2014-12-02: Form 8-K; Period of report 2014-12-02; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
- 2014-11-12: Form 8-K; Period of report 2014-11-12; Description 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events; Details 5.03.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2014-12-02 | 8-K | 2014-12-02 | 2.02 Results of Operations and Financial Condition | 2.02 On December 2, 2014, Nevro Corp. (“Nevro” or the “Company”) issued a press release relating to its financial results for the three and nine months ended September 30, 2014. | d826841d8k.htm |
| 2014-11-12 | 8-K | 2014-11-12 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 5.03 On November 12, 2014, Nevro Corp.’s (“Nevro” or the “Company”) amended and restated certificate of incorporation (the “Certificate of Incorporation”) filed with the Secretary of State of the State of Delaware and its amended and restated bylaws (the “Bylaws”) became effective in connection with the closing of the initial public offering of shares of the Company’s common stock. 8.01 On November 12, 2014, the Company completed its initial public offering of 8,050,000 shares of its common stock at a price to the public of $18.00 per share, which includes the exercise in full by the underwriters of the offering of their option to purchase 1,050,000 shares of the Company’s common stock. | a14-24281_18k.htm |